These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11310669)

  • 1. Synthesis and gastrointestinal prokinetic activity of novel benzamide derivatives with amphoteric side chains.
    Sakaguchi J; Iwsaki N; Iwanaga Y; Saito T; Takahara E; Kato H; Hanaoka M
    Chem Pharm Bull (Tokyo); 2001 Apr; 49(4):424-36. PubMed ID: 11310669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and structure-activity relationships of 4-amino-5-chloro-N-(1,4-dialkylhexahydro-1,4-diazepin-6-yl)-2-methoxybenzamide derivatives, novel and potent serotonin 5-HT3 and dopamine D2 receptors dual antagonist.
    Hirokawa Y; Harada H; Yoshikawa T; Yoshida N; Kato S
    Chem Pharm Bull (Tokyo); 2002 Jul; 50(7):941-59. PubMed ID: 12130853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KDR-5169, a new gastrointestinal prokinetic agent, enhances gastric contractile and emptying activities in dogs and rats.
    Tazawa S; Masuda N; Koizumi T; Kitazawa M; Nakane T; Miyata H
    Eur J Pharmacol; 2002 Jan; 434(3):169-76. PubMed ID: 11779580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel 5-hydroxytryptamine 4 (5-HT4) receptor agonists. Synthesis and gastroprokinetic activity of 4-amino-N-[2-(1-aminocycloalkan-1-yl)ethyl]-5-chloro-2-methoxybenzamide s.
    Suzuki T; Imanishi N; Itahana H; Watanuki S; Miyata K; Ohta M; Nakahara H; Yamagiwa Y; Mase T
    Chem Pharm Bull (Tokyo); 1998 Jul; 46(7):1116-24. PubMed ID: 9692218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and pharmacological properties of benzamide derivatives as selective serotonin 4 receptor agonists.
    Sonda S; Katayama K; Kawahara T; Sato N; Asano K
    Bioorg Med Chem; 2004 May; 12(10):2737-47. PubMed ID: 15110855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The selective 5-hydroxytryptamine (5-HT)4-receptor agonist RS67506 enhances lower intestinal propulsion in mice.
    Nagakura Y; Ito H; Kiso T; Naitoh Y; Miyata K
    Jpn J Pharmacol; 1997 Jun; 74(2):209-12. PubMed ID: 9243330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and structure-activity relationship of 3-Substituted benzamide, benzo [b]furan-7-carboxamide, 2,3-dihydrobenzo[b]furan-77-carboxamide, and indole-5-carboxamide derivatives as selective serotonin 5-HT4 receptor agonists.
    Kakigami T; Usui T; Tsukamoto K; Kataoka T
    Chem Pharm Bull (Tokyo); 1998 Jan; 46(1):42-52. PubMed ID: 9468636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substituted benzamides with conformationally restricted side chains. 1. Quinolizidine derivatives as selective gastric prokinetic agents.
    Hadley MS; King FD; McRitchie B; Turner DH; Watts EA
    J Med Chem; 1985 Dec; 28(12):1843-7. PubMed ID: 4068007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological profile of DA-6886, a novel 5-HT4 receptor agonist to accelerate colonic motor activity in mice.
    Lee MJ; Cho KH; Park HM; Sung HJ; Choi S; Im W
    Eur J Pharmacol; 2014 Jul; 735():115-22. PubMed ID: 24769304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological properties of a novel gastrointestinal prokinetic benzamide selective for human 5-HT4 receptor versus human 5-HT3 receptor.
    Nagakura Y; Akuzawa S; Miyata K; Kamato T; Suzuki T; Ito H; Yamaguchi T
    Pharmacol Res; 1999 May; 39(5):375-82. PubMed ID: 10328995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azaadamantane benzamide 5-HT4 agonists: gastrointestinal prokinetic SC-54750.
    Becker DP; Flynn DL; Shone RL; Gullikson G
    Bioorg Med Chem Lett; 2004 Nov; 14(22):5509-12. PubMed ID: 15482914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of novel 2-oxo-1,2-dihydro-3-quinolinecarboxamide derivatives as serotonin 5-HT4 receptor agonists.
    Suzuki M; Ohuchi Y; Asanuma H; Kaneko T; Yokomori S; Ito C; Isobe Y; Muramatsu M
    Chem Pharm Bull (Tokyo); 2000 Dec; 48(12):2003-8. PubMed ID: 11145160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel benzamides as selective and potent gastric prokinetic agents. 1. Synthesis and structure-activity relationships of N-[(2-morpholinyl)alkyl]benzamides.
    Kato S; Morie T; Hino K; Kon T; Naruto S; Yoshida N; Karasawa T; Matsumoto J
    J Med Chem; 1990 May; 33(5):1406-13. PubMed ID: 2139471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of novel 2-oxo-1,2-dihydro-3-quinolinecarboxamide derivatives as potent and selective serotonin 5-HT4 receptor agonists.
    Suzuki M; Ohuchi Y; Asanuma H; Kaneko T; Yokomori S; Ito C; Isobe Y; Muramatsu M
    Chem Pharm Bull (Tokyo); 2001 Jan; 49(1):29-39. PubMed ID: 11201221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and pharmacological evaluation of benzamide derivatives as selective 5-HT(4) receptor agonists.
    Sonda S; Kawahara T; Katayama K; Sato N; Asano K
    Bioorg Med Chem; 2005 May; 13(9):3295-308. PubMed ID: 15809165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of orally active benzamide derivatives as potent serotonin 4 receptor agonist.
    Sonda S; Kawahara T; Murozono T; Sato N; Asano K; Haga K
    Bioorg Med Chem; 2003 Sep; 11(19):4225-34. PubMed ID: 12951153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel N-[1-(1-substituted 4-piperidinylmethyl)-4-piperidinyl]benzamides as potent colonic prokinetic agents.
    Harada H; Yamazaki H; Toyotomi Y; Tateishi H; Mine Y; Yoshida N; Kato S
    Bioorg Med Chem Lett; 2002 Mar; 12(6):967-70. PubMed ID: 11959005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and structure-affinity relationships of novel N-(1-ethyl-4-methylhexahydro-1,4-diazepin-6-yl)pyridine-3-carboxamides with potent serotonin 5-HT3 and dopamine D2 receptor antagonistic activity.
    Hirokawa Y; Fujiwara I; Suzuki K; Harada H; Yoshikawa T; Yoshida N; Kato S
    J Med Chem; 2003 Feb; 46(5):702-15. PubMed ID: 12593651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The gastrointestinal motor effect of benzamide derivatives is unrelated to 5-HT3 receptor blockade.
    Schiavone A; Volonté M; Micheletti R
    Eur J Pharmacol; 1990 Oct; 187(3):323-9. PubMed ID: 2073919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substituted benzamides with conformationally restricted side chains. 2. Indolizidine derivatives as central dopamine receptor antagonists.
    King FD; Hadley MS; McClelland CM
    J Med Chem; 1988 Sep; 31(9):1708-12. PubMed ID: 2900897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.